Transforming Your Breast Cancer Care
Clinical Trials are an excellent option.
on Breast Cancer Conversations, the podcast
Meet the People Behind the Amelia Study!
Clinical Trials 101
Breast cancer clinical trials offer hope to many women and men diagnosed with the disease. They provide access to cutting-edge treatments that are not yet available to the general public.
1. Our Specialties
You get a tailored curated list of clinical trials from experts who are doing cutting edge research and have partnered with SBC to bring these trials to you!
2. Featured Projects
Relationships are key for any cancer care. We have taken the time to meet with the scientists, the researchers and the principle investigators engaging in the research and trials we bring to you, our SBC community members!
3. Resources
We are not just highlighting trials, we are providing you with an in-depth look at the trial through interviews with the researchers, expert blogs and fireside chats with the scientists, and access to reliable opportunities.
4. The Latest
Clinical trials provide you with access to the lastest resources and access to some of the best people in the world who are dedicating their lives to ending cancer. You don't just get the standard of care, you get above and beyond the standard!
ARETHA-1 Study
for Metastatic Triple Negative Breast Cancer
A Phase II Study of Evexomostat plus Eribulin for People with Triple-Negative Breast Cancer
Phase 2 Randomized Control Trial of Evexomostat (SDX-7320) in Combination with Eribulin for Patients with Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study
This study is being conducted at Memorial Sloan Kettering Cancer Center.
Amelia 1
for HR+ (estrogen or progesterone), Her2-, metastatic breast cancer with a PIK3CA gene mutation and previously treated with a CDK 4/6 inhibitor (e.g., Ibrance®) in1st line setting
​
​
The Amelia 1 clinical study is testing a new, experimental cancer treatment called Evexomostat to see if it prolongs patient treatment when combined with Piqray® and Faslodex® and if it helps control blood glucose spikes.
Our Clinical Trial Partners
Food for Thought
Study of Food and Brain Health in women
being treated for Triple Negative breast cancer
A research team at The Ohio State University in Columbus, OH, is recruiting participants for a remote study of diet and cognition among breast cancer patients. You might be eligible for this
study if you:
ï‚· Are female
ï‚· Were recently diagnosed with stage II-III triple-negative breast cancer
ï‚· Have just started, or soon will start systemic therapy (e.g. chemotherapy, targeted or
endocrine therapies)
ï‚· Are 40-65 years old
​
Enrolled participants will be randomized to receive a personalized 12-week nutrition intervention for cognitive health with a registered dietitian-nutritionist or a 12-week general healthy lifestyle program, and will complete all study visits remotely. Participants will be contacted 6 months after the intervention for data collection. If you are interested in this study and would like to find out if you are eligible to participate, please complete a brief screening survey and someone from the research team will
contact you directly.
​
Sexual Health And REhabilitation Online (SHAREonline): A Research Study for Young Female Cancer Survivors
Facing Changes in Sexual Health & Sexual Function
Researchers at the Dana-Farber Cancer Institute are conducting a research study: “Sexual Health and Rehabilitation Online” (SHAREonline), for women age 19-49 who are experiencing changes in sexual functioning after cancer treatment.
For more information visit sharesurvivorship.com or email share@dfci.harvard.edu.
Researchers at the University of Connecticut are seeking individuals with metastatic breast cancer to participate in a study about couples’ intimacy. We hope the findings from the study will be useful for individuals facing metastatic cancer by identifying communication practices that help couples manage the challenges of cancer on their relationship. Eligible participants will be asked to complete a 45-minute online survey that
includes scales and open-ended questions. Interested participants can complete this brief 5-minute screening survey: https://tinyurl.com/UConnMBCStudy
